Article
Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey.
Clinics and research in hepatology and gastroenterology - 1 May 2021
Basile Debora, Gallois Claire, Puglisi Fabio, Cohen Romain, Goere Diane, Aprile Giuseppe, Lepage Come, Laurent-Puig Pierre, Di Maio Massimo, Lecomte Thierry, Pernot Simon, Zaanan Aziz, Taieb Julien
Abstract excerpt
BACKGROUND: Increasing evidence shows that circulating tumor DNA (ctDNA) is a valuable tool in providing molecular, prognostic, predictive and dynamic information in colorectal cancer (CRC) patients. This study aimed to make a picture of knowledge, practice, attitudes and expectations about ctDNA in CRC patients. MATERIAL AND METHODS: An online CRC-ctdna survey was distributed from November 2019 to January 2020...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.